Morera-Herreras T[au] - Search Results

Year	Number of Results
2007	1
2008	1
2010	4
2011	1
2012	2
2013	2
2014	2
2015	1
2016	2
2018	1
2019	6
2020	3
2021	4
2022	3
2023	1

1

Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.

Zubelzu M, Morera-Herreras T, Irastorza G, Gómez-Esteban JC, Murueta-Goyena A. Zubelzu M, et al. Among authors: morera herreras t. Parkinsonism Relat Disord. 2022 Jun;99:107-115. doi: 10.1016/j.parkreldis.2022.06.001. Epub 2022 Jun 8. Parkinsonism Relat Disord. 2022. PMID: 35717321 Free article. Review.

2

The Noradrenergic System in Parkinson's Disease.

Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C. Paredes-Rodriguez E, et al. Among authors: morera herreras t. Front Pharmacol. 2020 Apr 8;11:435. doi: 10.3389/fphar.2020.00435. eCollection 2020. Front Pharmacol. 2020. PMID: 32322208 Free PMC article. Review.

3

Antipsychotics as environmental pollutants: An underrated threat?

Escudero J, Muñoz JL, Morera-Herreras T, Hernandez R, Medrano J, Domingo-Echaburu S, Barceló D, Orive G, Lertxundi U. Escudero J, et al. Among authors: morera herreras t. Sci Total Environ. 2021 May 15;769:144634. doi: 10.1016/j.scitotenv.2020.144634. Epub 2021 Jan 9. Sci Total Environ. 2021. PMID: 33485196 Review.

4

Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.

Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T. Antonazzo M, et al. Among authors: morera herreras t. Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28. Int Rev Neurobiol. 2019. PMID: 31349929 Review.

5

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.

Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L. Miguelez C, et al. Among authors: morera herreras t. Front Neural Circuits. 2014 Mar 17;8:21. doi: 10.3389/fncir.2014.00021. eCollection 2014. Front Neural Circuits. 2014. PMID: 24672433 Free PMC article. Review.

6

GABAergic circuits control spike-timing-dependent plasticity.

Paille V, Fino E, Du K, Morera-Herreras T, Perez S, Kotaleski JH, Venance L. Paille V, et al. Among authors: morera herreras t. J Neurosci. 2013 May 29;33(22):9353-63. doi: 10.1523/JNEUROSCI.5796-12.2013. J Neurosci. 2013. PMID: 23719804 Free PMC article.

7

Environmental enrichment shapes striatal spike-timing-dependent plasticity in vivo.

Morera-Herreras T, Gioanni Y, Perez S, Vignoud G, Venance L. Morera-Herreras T, et al. Sci Rep. 2019 Dec 19;9(1):19451. doi: 10.1038/s41598-019-55842-z. Sci Rep. 2019. PMID: 31857605 Free PMC article.

8

Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study.

Zazu L, Morera-Herreras T, Garcia M, Aguirre C, Lertxundi U. Zazu L, et al. Among authors: morera herreras t. Eur Neuropsychopharmacol. 2021 Sep;50:107-111. doi: 10.1016/j.euroneuro.2021.05.001. Epub 2021 May 31. Eur Neuropsychopharmacol. 2021. PMID: 34082277

9

Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation.

Vegas-Suárez S, Morera-Herreras T, Requejo C, Lafuente JV, Moratalla R, Miguélez C, Ugedo L. Vegas-Suárez S, et al. Among authors: morera herreras t. Front Pharmacol. 2022 Aug 30;13:953652. doi: 10.3389/fphar.2022.953652. eCollection 2022. Front Pharmacol. 2022. PMID: 36133803 Free PMC article.

10

Endocannabinoid modulation of dopaminergic motor circuits.

Morera-Herreras T, Miguelez C, Aristieta A, Ruiz-Ortega JÁ, Ugedo L. Morera-Herreras T, et al. Front Pharmacol. 2012 Jun 12;3:110. doi: 10.3389/fphar.2012.00110. eCollection 2012. Front Pharmacol. 2012. PMID: 22701427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results